Overview:Topics included will include the filing of New Drug Submissions for various types of pharmaceutical companies, priority submissions, organization of Health Canada, process for approval of applications, timeframes and cost for approval. We will cover the review of New Drugs and Old Drugs. Also included will be Natural Health Products. Canada has pricing controls, unlike the US. Reimbursement in Canada is very much related to the healthcare system in Canada. An overview of reimbursement will be covered.Why should you attend:Understanding the process in Canada for the registration of new chemical entities, generic products, 505(b)(2) equivalent submissions, biosimilars will open this market to your company. This seminar will provide you with clear guidance in terms of how to manage your registration activities in Canada. Included will be a discussion of postmarketing changes, advertising, pharmacovigilance, pricing control and reimbursement.Who Will Benefit:Regulatory Affairs Personnel (Coordinator, Manager, Director, VP)General ManagersMarketing (manager, Director, VP)Business Development personnelQuick Contact:NetZealous BDA as GlobalCompliancePanel USA Phone:1-800-447-9407Fax: 302-288-6884